PL1617876T3 - Tor-227 do zastosowania w radioterapii choroby tkanek miękkich - Google Patents

Tor-227 do zastosowania w radioterapii choroby tkanek miękkich

Info

Publication number
PL1617876T3
PL1617876T3 PL04727587T PL04727587T PL1617876T3 PL 1617876 T3 PL1617876 T3 PL 1617876T3 PL 04727587 T PL04727587 T PL 04727587T PL 04727587 T PL04727587 T PL 04727587T PL 1617876 T3 PL1617876 T3 PL 1617876T3
Authority
PL
Poland
Prior art keywords
thorium
radiotherapy
soft tissue
tissue disease
disease
Prior art date
Application number
PL04727587T
Other languages
English (en)
Inventor
Roy Larsen
Oyvind Bruland
Original Assignee
Algeta Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0308731.9A external-priority patent/GB0308731D0/en
Application filed by Algeta Asa filed Critical Algeta Asa
Publication of PL1617876T3 publication Critical patent/PL1617876T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
PL04727587T 2003-04-15 2004-04-15 Tor-227 do zastosowania w radioterapii choroby tkanek miękkich PL1617876T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0308731.9A GB0308731D0 (en) 2003-04-15 2003-04-15 Method of radiotherapy
PCT/GB2004/001654 WO2004091668A1 (en) 2003-04-15 2004-04-15 Thorium-227 for use in radiotherapy of soft tissue disease
EP04727587.0A EP1617876B1 (en) 2003-04-15 2004-04-15 Thorium-227 for use in radiotherapy of soft tissue disease

Publications (1)

Publication Number Publication Date
PL1617876T3 true PL1617876T3 (pl) 2015-03-31

Family

ID=35385222

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04727587T PL1617876T3 (pl) 2003-04-15 2004-04-15 Tor-227 do zastosowania w radioterapii choroby tkanek miękkich

Country Status (19)

Country Link
EP (1) EP1617876B1 (pl)
JP (2) JP5006032B2 (pl)
KR (2) KR101274867B1 (pl)
CN (1) CN100586484C (pl)
AU (1) AU2004229218B2 (pl)
BR (1) BRPI0409387B8 (pl)
CA (1) CA2522148C (pl)
CY (1) CY1115407T1 (pl)
DK (1) DK1617876T3 (pl)
EA (1) EA008195B1 (pl)
ES (1) ES2486845T3 (pl)
HK (1) HK1094150A1 (pl)
IL (1) IL171148A (pl)
MX (1) MXPA05010804A (pl)
NO (1) NO332931B1 (pl)
NZ (3) NZ543044A (pl)
PL (1) PL1617876T3 (pl)
PT (1) PT1617876E (pl)
ZA (1) ZA200507983B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ543044A (en) * 2003-04-15 2010-04-30 Algeta As Thorium-227 for use in radiotherapy of soft tissue disease
GB201002508D0 (en) * 2010-02-12 2010-03-31 Algeta As Product
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201105298D0 (en) * 2011-03-29 2011-05-11 Algeta Asa Pharmaceutical preparation
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
GB201600154D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
ES2952744T3 (es) 2016-12-15 2023-11-03 Nestle Sa Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía
FR3088769B1 (fr) * 2018-11-15 2020-12-25 Orano Med Procede de preparation d'au moins un generateur a haute teneur en radium-228
RU2767567C1 (ru) * 2020-10-27 2022-03-17 Станислав Анатольевич Дороватовский Комплексные соединения, содержащие в своем составе радионуклид 227Th, а также бисфосфонатный фрагмент, способы их получения, а также потенциальное применение в качестве действующего вещества в составе остеотропного радиофармацевтического лекарственного препарата

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053196T3 (es) * 1989-06-19 1994-07-16 Akzo Nv Metodo para la produccion de un radioinmunoconjugado.
WO1993020852A2 (en) * 1992-04-13 1993-10-28 The Dow Chemical Company Macrocyclic chelating agents, chelates and conjugates thereof
MY133346A (en) * 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
EP1227849A2 (en) * 2000-02-25 2002-08-07 Dangshe Ma Actinium-225 complexes and conjugates for radioimmunotherapy
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
NZ543044A (en) * 2003-04-15 2010-04-30 Algeta As Thorium-227 for use in radiotherapy of soft tissue disease

Also Published As

Publication number Publication date
JP5006032B2 (ja) 2012-08-22
IL171148A (en) 2013-12-31
PT1617876E (pt) 2014-08-04
EA008195B1 (ru) 2007-04-27
EP1617876B1 (en) 2014-05-14
NZ595758A (en) 2013-02-22
CN1805760A (zh) 2006-07-19
CY1115407T1 (el) 2017-01-04
JP2006523664A (ja) 2006-10-19
JP2012051942A (ja) 2012-03-15
KR101274867B1 (ko) 2013-06-13
AU2004229218B2 (en) 2009-05-07
MXPA05010804A (es) 2006-03-09
ES2486845T3 (es) 2014-08-19
NO332931B1 (no) 2013-02-04
KR20060015507A (ko) 2006-02-17
HK1094150A1 (en) 2007-03-23
NO20055390D0 (no) 2005-11-15
ZA200507983B (en) 2007-03-28
CN100586484C (zh) 2010-02-03
BRPI0409387B1 (pt) 2021-05-11
KR20110022743A (ko) 2011-03-07
JP5468597B2 (ja) 2014-04-09
CA2522148C (en) 2010-07-13
BRPI0409387B8 (pt) 2021-05-25
BRPI0409387A (pt) 2006-04-18
DK1617876T3 (da) 2014-07-21
NZ606996A (en) 2014-08-29
AU2004229218A1 (en) 2004-10-28
EA200501456A1 (ru) 2006-06-30
EP1617876A1 (en) 2006-01-25
NO20055390L (no) 2006-01-16
NZ543044A (en) 2010-04-30
CA2522148A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
HK1094150A1 (en) Thorium-227 for use in radiotherapy of soft tissue disease
EP1731113A4 (en) MEDICAL TREATMENT KIT
GB0520687D0 (en) Skin treatment formulations
IL173386A0 (en) Use of adcc-optimized antibodies for treating weak patients
GB0324761D0 (en) Use of compounds in therapy
EP1736173A4 (en) MEANS FOR THE TREATMENT OF TISSUE DAMAGE AND THERAPEUTIC PROCEDURE
GB0320238D0 (en) Treatment of disease
AU2003223451A8 (en) Methods for ultrasonic imaging and treating diseased tissues
GB0411403D0 (en) Irradiating body tissue
GB0702859D0 (en) Dressing for tissue treatment
GB0300428D0 (en) Medical treatment
AU2003274649A8 (en) Diagnostic markers for therapeutic treatment
GB0215051D0 (en) Simulated body tissue
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject
GB2432322B (en) Gel for tissue treatment
GB0306165D0 (en) Medical treatment
GB0328870D0 (en) Characterising body tissue
GB0411400D0 (en) Imaging body tissue
GB0208194D0 (en) Treatment of disease
HU0302933D0 (en) Treatment of diseases
GB0302801D0 (en) Therapeutic methods and compositions for use therein
GB0303165D0 (en) Therapeutic methods and compositions for use therein
GB0310251D0 (en) Therapeutic methods and compositions for use therein
GB0326870D0 (en) Therapeutic methods and compositions for use therein
GB0310463D0 (en) Therapeutic agents for the treatment of bone conditions